Multivariate clinical models and quantitative dipyridamole-thallium imaging to predict cardiac morbidity and death after vascular reconstruction.
Patients with peripheral vascular disease have a high prevalence of coronary artery disease and are at increased risk for cardiac morbidity and death after vascular reconstruction. The present study was undertaken to assess the value of 18 clinical parameters, of 7 clinical scoring systems, and of quantitative dipyridamole-thallium imaging for predicting the occurrence of postoperative myocardial infarction or cardiac death. Vascular surgery was performed in 125 patients. Thirteen postoperative cardiac events occurred, including 10 cardiac deaths and 3 nonfatal infarctions. Clinical parameters were not useful in predicting postoperative outcome. All 63 patients with normal scan results or fixed perfusion defects underwent surgery uneventfully, whereas 21% (13/62) of patients with reversible defects had a postoperative cardiac complication. By use of quantitative scintigraphic indexes we found that patients with reversible defects could be stratified into intermediate and high-risk subgroups with postoperative event rates of 5% (2/47) and 85% (11/13), respectively, despite intensive postoperative monitoring and antianginal medication. Thus in patients unable to complete a standard exercise stress test, postoperative outcome cannot be predicted clinically, whereas dipyridamole-thallium imaging successfully identified all patients who had a postoperative cardiac event. By use of quantification we found that patients with reversible defects can be stratified into an intermediate risk subgroup that can undergo surgery with minimal complication rate and a high-risk subgroup that requires coronary angiography.
Lette
J
J
Department of Medicine, Maisonneuve Hospital Centre, Montreal, Quebec, Canada.
Waters
D
D
Lassonde
J
J
René
P
P
Picard
M
M
Laurendeau
F
F
Levy
R
R
Cerino
M
M
Nattel
S
S
D002170:Canada; D003645:Death, Sudden / Q000453:epidemiology*; D004176:Dipyridamole / Q000009:adverse effects; D006321:Heart / Q000000981:diagnostic imaging*; D006801:Humans; D008955:Models, Cardiovascular; D015999:Multivariate Analysis; D009203:Myocardial Infarction / Q000000981:diagnostic imaging* / Q000453:epidemiology / Q000401:mortality; D011183:Postoperative Complications / Q000000981:diagnostic imaging* / Q000453:epidemiology / Q000401:mortality; D011379:Prognosis; D011877:Radionuclide Imaging; D012307:Risk Factors; D013794:Thallium Radioisotopes / Q000009:adverse effects; D014481:United States; D014656:Vascular Surgical Procedures / Q000706:statistics & numerical data
D013794:Thallium Radioisotopes; D004176:Dipyridamole